APDN vs. IZEA, LICY, HTCR, LUNA, FPAY, BTCM, SWVL, AERT, EHGO, and SJ
Should you be buying Applied DNA Sciences stock or one of its competitors? The main competitors of Applied DNA Sciences include IZEA Worldwide (IZEA), Li-Cycle (LICY), HeartCore Enterprises (HTCR), Luna Innovations (LUNA), FlexShopper (FPAY), BIT Mining (BTCM), Swvl (SWVL), Aeries Technology (AERT), Eshallgo (EHGO), and Scienjoy (SJ). These companies are all part of the "business services" industry.
Applied DNA Sciences vs.
IZEA Worldwide (NASDAQ:IZEA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.
Applied DNA Sciences has lower revenue, but higher earnings than IZEA Worldwide. IZEA Worldwide is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.
Applied DNA Sciences has a consensus price target of $1.50, suggesting a potential upside of 683.70%. Given Applied DNA Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Applied DNA Sciences is more favorable than IZEA Worldwide.
15.6% of IZEA Worldwide shares are held by institutional investors. Comparatively, 22.2% of Applied DNA Sciences shares are held by institutional investors. 4.9% of IZEA Worldwide shares are held by company insiders. Comparatively, 0.2% of Applied DNA Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Applied DNA Sciences had 2 more articles in the media than IZEA Worldwide. MarketBeat recorded 2 mentions for Applied DNA Sciences and 0 mentions for IZEA Worldwide. Applied DNA Sciences' average media sentiment score of 0.50 beat IZEA Worldwide's score of 0.00 indicating that Applied DNA Sciences is being referred to more favorably in the news media.
IZEA Worldwide has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Comparatively, Applied DNA Sciences has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.
IZEA Worldwide has a net margin of -46.65% compared to Applied DNA Sciences' net margin of -203.76%. IZEA Worldwide's return on equity of -26.06% beat Applied DNA Sciences' return on equity.
Applied DNA Sciences received 129 more outperform votes than IZEA Worldwide when rated by MarketBeat users. However, 64.57% of users gave IZEA Worldwide an outperform vote while only 58.02% of users gave Applied DNA Sciences an outperform vote.
Summary
Applied DNA Sciences beats IZEA Worldwide on 10 of the 18 factors compared between the two stocks.
Get Applied DNA Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Applied DNA Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:APDN) was last updated on 1/21/2025 by MarketBeat.com Staff
